About this trial
The purpose of this study is to assess the surgeon experience and surgery outcomes in participants undergoing index Lapidus procedure for the correction of hallux valgus (a foot deformity where the big toe angles outward towards the other toes, causing a painful bony bump at the base of the big toe joint) using the VIRTUGUIDE System and compatible DePuy Synthes Lapidus implants.
Eligibility criteria
Qualifiers
Participants, both male and female, >= 22 years old at the time of consent
Participants undergoing a primary Lapidus procedure for the correction of hallux valgus using the VIRTUGUIDE System (software + instruments) and who receive a compatible DePuy Synthes Lapidus implant
Participants must be able to read and understand questions and responses in an available translated language for patient reported outcomes (PROMs)
All primary Lapidus fixation implants are used on-label according to the implant IFU/FDA cleared labeling
Disqualifiers
Participation in any other medical device or medicinal product study within the previous month. Participation in observational studies is allowed
In the opinion of the Principal Investigator, the subject is unable to comply with the requirements of the registry
Participant has known allergies to implant components
Participant presenting for a revision of a Lapidus procedure
Trial design
Treatments tested in this trial
- Not listed